Institut atlantique de recherche sur le cancer inc. / Atlantic Cancer Research I: federal grants and contributions: 8 agreements; $19.6M value; 1 departments; 3 programs.
Assay record ASY-CA-188IHZT17M · Cite as: Assay Systems, “Institut atlantique de recherche sur le cancer inc. / Atlantic Cancer Research I: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/institut-atlantique-de-recherche-sur-le-cancer-inc-atlantic-cancer-research-i/
Support innovation and commercialization activities
Delivering Precision Medicine through Liquid Biopsy Technologies
Genomically-guided biomarker discovery for cancer
Discovery and development of novel cancer therapeutic
Next generation biomarker techn. for cancer early detection
Develop technology platform to predict best cancer treatment options
Develop minimally invasive technology in the treatment of cancer tumors
Business Development/Marketing Position
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.